{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:42:53Z","timestamp":1758040973439,"version":"3.44.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.ajog.2007.06.032","type":"journal-article","created":{"date-parts":[[2007,9,8]],"date-time":"2007-09-08T07:18:08Z","timestamp":1189235888000},"page":"262.e1-262.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting"],"prefix":"10.1016","volume":"197","author":[{"given":"Charles","family":"Rittenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niki","family":"Istwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie","family":"Rhea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Stanziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2007.06.032_bib1","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2007.06.032_bib2","first-page":"1115","article-title":"ACOG committee opinion, number 291","volume":"102","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2007.06.032_bib3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ajog.2006.06.034","article-title":"Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: a 2005 follow-up survey","volume":"195","author":"Ness","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2007.06.032_bib4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","article-title":"A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins","volume":"357","author":"Rouse","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2007.06.032_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/14767050601152845","article-title":"Gestational age at initiation of 17 alpha-hydroxyprogesterone caproate (17P) and recurrent preterm delivery","volume":"20","author":"Gonzalez-Quintero","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2007.06.032_bib6","first-page":"e1","article-title":"Increased recurrence of preterm delivery with early cessation of 17 alpha-hydroxyprogesterone caproate","volume":"224","author":"Rebarber","year":"2007","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937807007612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937807007612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:22:22Z","timestamp":1757586142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937807007612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0002937807007612"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2007.06.032","relation":{},"ISSN":["0002-9378"],"issn-type":[{"type":"print","value":"0002-9378"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2007.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}